MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析

◆英語タイトル:MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011070
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It also developed a line of breath-powered, dry powder inhalers. Mannkind develops its products based on Technosphere drug delivery platform, its proprietary formulation technology. It also utilizes inhalation profiling technologies such as BluHale. It conducts its manufacturing operations in Danbury, Connecticut and sells its products in the US through a direct sales force. MannKind is headquartered in California, the US.

MannKind Corp (MNKD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MannKind Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MannKind Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MannKind Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MannKind Corp, Medical Equipment, Deal Details 11
Partnerships 11
MannKind and One Drop to Enter into Agreement 11
Equity Offering 12
Mannkind to Raise USD61 Million in Private Placement of Shares 12
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 14
MannKind Raises USD36.2 Million in Private Placement of Shares 15
Mannkind Raises USD50 Million in Private Placment of Shares 16
MannKind Announces Public Offering Of Common Stock For US$50 Million 18
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 19
MannKind Completes Public Offering Of Units For US$86 Million 20
Debt Offering 22
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 22
MannKind Plans Public Offering Of Senior Secured Discount Notes Due 2017 For US$370 Million 24
MannKind Corp – Key Competitors 25
MannKind Corp – Key Employees 26
MannKind Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Sep 05, 2017: MannKind Relocates Headquarters to Westlake Village 28
Financial Announcements 29
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 29
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 31
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 32
Nov 09, 2016: MannKind Reports 2016 Third Quarter Financial Results 34
Aug 08, 2016: MannKind Reports 2016 Second Quarter Financial Results 36
May 09, 2016: MannKind Reports 2016 First Quarter Financial Results 37
Mar 14, 2016: MannKind Reports 2015 Fourth Quarter and Full Year Financial Results 38
Corporate Communications 39
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 39
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 40
Jun 28, 2017: Mannkind draws remaining funds under mann group loan arrangement 41
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 42
Apr 19, 2016: MannKind Expands Commercial Capabilities With Two New Hires 43
Mar 14, 2016: MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer 44
Feb 19, 2016: Alfred Mann Steps Down as Executive Chairman of Mannkind 45
Jan 11, 2016: MannKind Provides Update on Senior Management 46
Other Significant Developments 47
Jan 03, 2017: MannKind Receives $1 Million Milestone From RLS 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
MannKind Corp, Medical Equipment, Key Facts, 2016 2
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MannKind Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MannKind Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MannKind Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MannKind Corp, Deals By Market, 2011 to YTD 2017 9
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MannKind and One Drop to Enter into Agreement 11
Mannkind to Raise USD61 Million in Private Placement of Shares 12
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 14
MannKind Raises USD36.2 Million in Private Placement of Shares 15
Mannkind Raises USD50 Million in Private Placment of Shares 16
MannKind Announces Public Offering Of Common Stock For US$50 Million 18
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 19
MannKind Completes Public Offering Of Units For US$86 Million 20
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 22
MannKind Plans Public Offering Of Senior Secured Discount Notes Due 2017 For US$370 Million 24
MannKind Corp, Key Competitors 25
MannKind Corp, Key Employees 26
MannKind Corp, Other Locations 27

★海外企業調査レポート[MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析
    Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • 3W Power S.A. (3W9K):電力:M&Aディール及び事業提携情報
    Summary 3W Power S.A. (3W Power) is a provider of energy equipment and services. It offers power supply systems and solutions. The company provides the most comprehensive product and service portfolios in uninterruptible power supply and power management fields. 3W Power offers a range of services s …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cameron International Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Ahli Bank Qsc
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aviva Ltd.:企業の戦略・SWOT・財務分析
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sanofi SA:戦略・SWOT・企業財務分析
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Purdue Pharma Canada-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Dare Bioscience Inc (DARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that concentrates on protein analytics. The organization offers services including protein characterization, services for biopharmaceuticals, biosimilars services an …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆